BiPar Sciences
Latest round
- Series C
Last raised
- Dec 2008
Total raised
- $45M
Investors
- 6
About BiPar Sciences
BiPar is a clinical-stage drug development company pioneering novel tumor-selective therapies designed to address urgent unmet needs of cancer patients.
Who invested in BiPar Sciences
6 investors across 3 rounds
See all investors in BiPar Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BiPar Sciences
Who invested in BiPar Sciences?
BiPar Sciences has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BiPar Sciences raised?
BiPar Sciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did BiPar Sciences last raise money?
BiPar Sciences's most recent round on record is a Series C, in Dec 2008.
What does BiPar Sciences do?
BiPar is a clinical-stage drug development company pioneering novel tumor-selective therapies designed to address urgent unmet needs of cancer patients.
Where is BiPar Sciences headquartered?
BiPar Sciences is headquartered in South San Francisco, US.
Which VCs invest in companies like BiPar Sciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at BiPar Sciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like BiPar Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.